Cohance Lifesciences Schedules Q2 and H1FY27 Earnings Conference Call
Cohance Lifesciences Ltd 路 Intimation 路 06 Nov 2026, 6:30 pm
Cohance Lifesciences Schedules Q2 and H1FY27 Earnings Conference Call Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) has scheduled an earnings conference call for investors and analysts on 6th Nov'26 at 6:30 PM IST. The management will discuss the company's unaudited financial results for the quarter and half-year ended 30th Sep'26 (Q2 and H1FY27), which are slated for release earlier that day. The call will begin with management commentary followed by an interactive Q&A session. Primary domestic dial-in numbers include +91 22 6280 1141 and +91 22 7115 8042.
Original exchange filing (PDF)
More announcements from Cohance Lifesciences Ltd
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings .... 路 12 Nov 2026
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 12 Nov 2026
- Investors Meet 路 11 Nov 2026
- Transcript of Con call 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings Pvt Ltd & Others 路 11 Nov 2026
- Investor Presentation 路 07 Nov 2026
- Update on USFDA inspection at Pashamylaram Manufacturing facility. 路 07 Nov 2026
